Objective: This paper re-evaluates the requirements for iodine during pregnancy, lactation and the neonatal period, and formulates original proposals for the median concentrations of urinary iodine (UI) that indicate optimal iodine nutrition during these three critical periods of life. This paper also discusses the measurements that are used to explore thyroid functions during the same periods. Design: An extensive and critical review of the literature on thyroid physiopathology during the perinatal period. Setting: Human studies conducted in various regions throughout the world. Subjects: Pregnant women, lactating women, and newborns. Results: The following proposals are made after extensive review of the literature: the requirement for iodine by the mother during pregnancy is 250-300 mg day -1 ; during lactation the requirement is 225-350 mg day -1 ; and during the neonatal period the requirement of the infant is 90 mg day -1 . The median UI that indicates an optimal iodine nutrition during these three periods should be in the range of 150-230 mg day -1 . These figures are higher than recommended to date by the international agencies. Conclusions: Pregnant women and young infants, but especially the second group, are more sensitive to the effects of an iodine deficiency (ID) than the general population because their serum thyroid-stimulating hormone (TSH) and thyroxine are increased and decreased, respectively, for degrees of ID that do not seem to affect thyroid function in the general population. Systematic neonatal thyroid screening using primary TSH could be the most sensitive indicator to monitor the process of ID control.
Introduction
Iodine deficiency (ID) used to be a major public health problem. As recently as 1990, 28.9% of the world's population was at risk of a deficiency, 12.0% of the population exhibited goitre, 11.2 million individuals were affected by cretinism and another 43 million people had some degree of mental impairment due to ID 1 . Therefore, ID is the leading cause of preventable mental retardation during childhood. Concerted international action taken since 1990 has aimed at the sustainable elimination of ID disorders using salt iodisation as the main strategy 1,2 . Spectacular results have been achieved as the consumption of iodised salt has increased from some 5-10% of households in 1990 to 68% in 1999 3 . In countries where systematic and periodic monitoring has been used, these changes have resulted in a clear-cut improvement in iodine nutrition and thyroid function in the general population 4 -6 . However, in their latest evaluation of the control of ID in the world, the World Health Organization (WHO) reported that in 126 out of the 192 members states that have data on urinary iodine (UI), only 67 had an optimal status of iodine nutrition (a median UI concentration of between 100 and 200 mg l 21 ); 54 countries were still iodine deficient (median UI concentration , 100 mg l 21 ); and 4 countries had an excessive iodine intake (median UI concentration .200 mg l 21 )
7
. Therefore, it appears that major additional efforts are still required in order to reach the goal of the sustained elimination of ID in the world.
However, even in countries that have achieved iodine sufficiency, the status of iodine nutrition in pregnant and lactating women may still be inadequate. For example, in the United States of America, where the status of iodine nutrition is adequate in the general population, with a median UI concentration of 145 mg l 21 , 6.7% of pregnant women are nevertheless affected by moderate to severe ID and have a UI concentration below 50 mg per l 8 . This is probably largely due to the fact that women are recommended to limit their intake of salt during pregnancy, which includes iodised salt, but also because of the metabolic changes that occur during pregnancy and lactation that result in an increased requirement for iodine 9 -12 . Yet pregnant women are the most sensitive group in the population to the effects of ID, Maternal hypothyroxinaemia due to ID occurring early during gestation, even before the onset of foetal thyroid function, is the cause of irreversible brain damage in the foetus resulting in mental deficiency in the offspring 13 -18 . Therefore, the question arises of how to ensure and assess adequate iodine nutrition during pregnancy.
The objectives of this paper are:
1. To review critically, the scientific literature on iodine requirements during pregnancy, lactation and the neonatal period. 2. To offer practical recommendations regarding the value of the indicators of optimal iodine nutrition during these critical periods of life, with particular emphasis on normative values of UI concentration.
Requirements for iodine during pregnancy, lactation and the neonatal period
Pregnancy
The requirement of a mother for iodine is increased during pregnancy as a result of at least three factors: (1) an increased requirement for thyroxine (T 4 ) in order to maintain normal metabolism in the mother; (2) a transfer of T 4 and iodide from the mother to the foetus; and (3) a supposed greater than normal loss of iodide through the kidneys due to an increase in the renal clearance of iodide 11 . Because of these three factors, the recommended dietary intake of iodine during pregnancy is higher than the value of 150 mg day 21 recommended for non-pregnant adults and adolescents 19, 20 . When the intake is below the critical threshold of 150 mg day
21
, the iodine balance during pregnancy becomes negative 21 . The WHO, the UNICEF and the ICCIDD 19 recommend a daily iodine intake of 200 mg day 21 by pregnant women, a 33%
increase. The Institute of Medicine (IOM) of the US Academy of Sciences recommends a higher intake of 220 mg per day 20 , while other organisations recommend between 175 and 230 mg per day 22, 23 . During pregnancy, the daily production of T 4 in order to maintain the euthyroidism in hypothyroid women increases by 10 -150%, with a median increase of 40 -50% 24 -26 . This represents an additional 75 -150 mg of T 4 day 21 , which requires and estimated 50 -100 mg of iodine to make.
The amount of T 4 transferred from mother to foetus, including the period before the foetal thyroid gland starts to function, has not been quantified, but it has been estimated that up to 40% of the T 4 measured in cord blood at birth is of maternal origin (reviewed in reference 15).
The transfer of iodide from mother to foetus is also difficult to quantify, but three things need to be taken into consideration: that the iodine content of the foetal thyroid gland increases from ,2 mg at 17 weeks of gestation 27 to 300 mg at full term 28 -31 ; that the amount of iodine in foetal T 4 at term probably averages 500 mg
32
; and that the substitutive dose of T 4 in hypothyroid neonates is 50-75 mg per day 33, 34 . From this, it can be estimated that the transfer of iodide from mother to foetus represents some 50 mg day
21
. The estimate made by the IOM is 75 mg per day 20 . It is often stated that the increase in the iodine requirement of mothers during pregnancy is largely due to a greater loss of iodide through the kidney caused by an increase in renal clearance 11,35 -38 . This should serve to decrease the concentration of plasma inorganic iodide (PII) in serum. However, on the contrary, Liberman et al. 39 showed that there is no significant decline in the concentration of PII during pregnancy. In addition, as shown by the data summarised in Table 1 and reported by Dworkin et al.
, almost all studies of UI concentrations during pregnancy have shown that, in a given environment, the excretion of iodide is almost the same in pregnant women, non-pregnant women and the general population, irrespective of the status of iodine nutrition in each population. Only the studies conducted in Ireland, the United Kingdom and Sri Lanka 40, 41 , in Hong Kong 42 , and perhaps in Switzerland 43 have shown a clear-cut increase in UI excretion during pregnancy. The results reported in another Swiss study 44 are difficult to interpret because of the surprisingly low concentration of UI in a population known to be iodine sufficient 45 . On the other hand, some studies have shown that the UI concentration decreases during gestation 46 -48 . Therefore, it appears that the concept of an increased urinary loss of iodine during pregnancy is not firmly established and certainly cannot be quantified.
Finally, it has to be emphasised that there are no data available on the possible storage or loss of iodide from the placenta itself.
Taking all these factors into consideration, it can be estimated that the additional requirement for iodine during pregnancy is at least 100 -150 mg day 21 . Consequently, the minimum requirement for iodine during pregnancy is at least 250 mg day 21 , and is probably in the range of 250-300 mg day 21 . This figure is higher than 220 mg day 21 proposed by the IOM 20 , which did not take into account the increased production of T 4 during pregnancy.
Lactation
Considering that the iodine content of breast milk in conditions of iodine sufficiency is in the range of 150-180 mg per l 49,50 ( Table 2 ), and that some 0.5-1.1 l of milk is produced per day for the first 6 months of lactation, the daily excretion of iodine in human milk is estimated to be 75 -200 mg day 21 . Consequently, the iodine required by a lactating woman is estimated to be 225-350 mg day 21 .
The slight difference, if any, compared with the figure of 290 mg day 21 recommended by the IOM 20 , results from the use of recent data on the iodine content of breast milk 49, 50 .
Neonatal period
The iodine requirements of neonates and infants were first estimated to be equal to the mean iodine intake of exclusively breastfed neonates and young infants in iodine replete areas. Up to the late 1960s, the iodine content of breast milk of women in such areas was usually around 50 mg l 21 (reviewed in references [49] [50] [51] . Considering a daily intake of breast milk of 0.6-1.1 l by neonates and young infants, the assumption was made that an infant gets 30 -50 mg iodine per day in milk from an adequately fed mother 52 . However, the iodine content of breast milk is critically influenced by the dietary intake of the pregnant and lactating mother, and of the general population, and recently much higher figures have been recorded 49, 50 . For this reason, the iodine requirement of neonates has been evaluated from metabolic studies by determining the value that results in a situation of positive iodine balance, a state that is required in order to ensure a progressively increasing iodine pool in the thyroid gland of the growing infant. Such iodine balance studies were conducted in healthy preterm and fullterm infants aged approximately 1 month in Belgium, a country with a mildly iodine-deficient population 53 . These studies, reported extensively elsewhere 52 , indicate that the iodine intake required to achieve a positive iodine balance is at least 15 , but is still a bit lower than the present recommendation by the IOM of 110 mg per day 20 .
Indicators of iodine nutrition during pregnancy, lactation and the neonatal period UI Since more than 90% of the iodine absorbed by the body eventually appears in the urine, UI excretion is a good marker of recent dietary iodine intake 18 . This means that a median UI concentration ranging from 100 to 199 mg l 21 in the general population is considered to indicate an adequate iodine intake and optimal iodine nutrition 19 . Since the requirement for iodine is increased during pregnancy, the median UI concentration during pregnancy that indicates optimal iodine nutrition needs to be higher than 100 mg l
21
. Table 1 shows data from published studies in several countries that compares the UI concentration of pregnant women with the same in the general population. In Table 1 , the countries are arbitrarily listed according to a roughly decreasing iodine intake of the general population, starting with Chile 39 , whose population is exposed to an excessive iodine intake based on criteria given by the WHO, the UNICEF and the ICCIDD 19 , down to countries in which different degrees of mild to moderate ID have been documented. As indicated earlier, there is a striking similarity between the UI concentration of pregnant women and of the rest of the population in the same country, except in reports from Ireland and the UK 40, 41 where values during pregnancy are markedly and systematically higher than in nonpregnant controls. For this reason, it appears difficult to derive a reference value for a UI concentration during pregnancy and lactation from the data collected in countries with no ID, because this value varies from 800 mg l 21 in Chile 39 to 138 mg l 21 in Switzerland 43 , where the median UI in the general population is barely above the lower limit of normal. In Iran, where ID has been successfully eliminated 55 , the median UI concentration of pregnant women in four cities was found to vary from 186 to 403 mg l 21 (see paper by Azizi, this issue) and was roughly the same as values found in the general population in the same cities 56 . The values recorded in Iran during pregnancy are of the same order of magnitude . However, it has to be recognised that this figure of 8% corresponds almost exactly to the percentage of values (7.2%) below the threshold of 50 mg l
, indicating at least a moderate ID in a general population when the median is between 100 and 200 mg per l 57 . This percentage is considered to be acceptable 57 considering the welldocumented day-to-day variation in UI concentration, including during pregnancy 58 -61 . Taking these facts and factors into consideration, it can be concluded that the recommended median value for UI concentration during pregnancy and lactation has to be based on theoretical grounds. If, as in non-pregnant adults, the recommended median UI concentration of 100- , only slightly higher than the value recommended for non-pregnant adults.
It should be noted that the thyroid function and the thyroid volume remained normal during pregnancy in Iran 56 as well as in Chile 39 for the values of UI concentration twice as high as in Iran, which strongly suggests that these values are not excessive and not a potential source of side effects 62, 63 . On the contrary, in all countries whose populations experience some degree of ID, where the issue has been investigated, thyroid function is critically impaired during pregnancy and in the neonate, even when it remains normal in the general population 64 -68 . The anomalies are described in the next sub-section.
In summary, it appears that the recommended dietary intake of iodine during pregnancy of 250-300 mg day 21 and during lactation of 225-350 mg day
, should be higher than proposed, especially by the WHO, the UNICEF and the ICCIDD 19 , and that a median UI concentration in the range of 150-230 mg l 21 would indicate optimal iodine nutrition during pregnancy and lactation. Table 3 summarises data from papers published on the median UI concentration of neonates in countries or areas where the population is iodine sufficient and from countries with different degrees of ID. There is a large variation in values, even in iodine-sufficient countries, where concentrations range from 736 mg l 21 in Hokkaido, Japan 69 where people have an extremely high iodine intake 70 , to 96 mg l 21 in Stockholm 71 .
Again these data do not help substantially to identify the optimal UI concentration, therefore, it also has to be defined on the basis of theoretical considerations. Based on the iodine requirement of 90 mg day 21 and a urine volume passed by neonates of about 0.4-0.5 l per day 72 , the median UI concentration that indicates optimal iodine nutrition in neonates can be estimated to be about 180-225 mg l
, but ignoring the fact that the iodine balance of the neonate should also be positive in order to develop an iodine store in the thyroid gland. This concentration, which is higher than recommended for schoolchildren and adults, has been observed when healthy young infants are supplemented with a daily physiological dose of 90 mg day 21 of iodine 73 . It is also the value reported in some parts of the United States in which the population is supposed to be iodine sufficient 74, 75 . On the other hand, published studies in which the UI concentration has been determined simultaneously in mothers at delivery and in neonates during the first days of life 47, 76, 77 indicate that these concentrations are almost similar in mothers and neonates. Therefore, based on the assumption of an optimal UI in pregnant mothers, it can be estimated by extrapolation that the concentration of iodine in the urine of neonates should be around 150-230 mg l 21 , which is similar to the figure derived from the iodine requirements of the neonates. The data reported from neonates in conditions of mild, moderate and severe ID are indeed much lower than ideal, such as , 20 mg l 21 in German neonates 78 before the partly successful implementation of a programme of voluntary salt iodisation 79 . It is particularly interesting to observe that this concentration progressively increased with time in both Germany and Belgium, for example, following the implementation of programs of iodine supplementation 79, 80 or silent iodine prophylaxis respectively 81 . In summary, the recommended dietary intake of iodine in neonates is 90 mg day 21 and the median UI concentration to be expected when this requirement is met is 180-225 mg l
, a value similar to the one recommended for pregnant women.
Measurements exploring thyroid function
The final objective of campaigns to correct an ID is not only to normalise the iodine intake and UI concentration, but also to correct or prevent abnormalities of thyroid function and the development of goitre 1, 4, 19 . The measurements used to test thyroid function and assess iodine nutrition are the concentration in serum of thyrotropin (TSH), total T 4 and/or free T 4 , thyroglobulin (Tg) and triiodothyronine (T 3 ). To determine these variables requires blood, which is more invasive to collect than urine, especially for pregnant women and neonates.
The alterations of thyroid function during pregnancy that occur in conditions of ID are described and commented upon in detail elsewhere 82 , and within this supplement to Public Health Nutrition. They are characterised by a progressively decreasing concentration of free T 4 in serum and increasing concentrations of TSH and Tg during pregnancy, together with the development of thyroid hyperplasia. These abnormalities occur even in conditions of mild ID when they are not present in the general population in the same area, indicating the hypersensitivity of pregnant women to the effects of an ID 11, 48 . They are corrected by giving physiological doses of iodine (reviewed in reference 83) and can be prevented even in conditions of severe ID when injections of iodised oil are given before, or even during, gestation. However, the neurological defects of endemic cretinism are prevented only when the oil is administered before pregnancy begins 4 . The value of systematically determining the serum TSH concentration of pregnant women may not be justified in a country in which the population is generally iodine sufficient 84 .
In contrast to the situation in mothers, the alterations of thyroid function that occur in neonates experiencing ID are qualitatively similar but quantitatively much more marked, including particularly high serum TSH and Tg concentrations. The reason for this particular hypersensitivity to ID by the neonate is due to the small iodine stores in the neonatal thyroid, which has a very fast turnover (reviewed in reference 85). For this reason, the proposal was made to use neonatal thyroid screening programs which measure primary TSH as the principal monitoring tool in the evaluation of the degree of ID in communities, and of the effectiveness of programs of iodine supplementation 1, 85 . The neonatal TSH concentration assesses the saturation of receptors of brain cells with thyroid hormones and constitutes the single best indicator of the risk of brain damage and mental retardation 16 . In normal conditions, the proportion of neonates with a TSH , a value clearly lower than the recommended UI concentration both for adults and neonates 1 . Neonatal thyroid screening has been used as a monitoring tool in an increasing number of countries and regions (reviewed in references 85 -87) with occasional organisational difficulties 88 .
Conclusion
Pregnant and lactating women and neonates are the main victims of the effects of ID because of the impact of maternal, foetal and neonatal hypothyroxinaemia on brain development 13 -18 . Therefore, any program to correct ID in a population should pay special attention to these particular groups. However, as yet, there are no firm recommendations presently available on the concentration of UI that indicates optimal iodine nutrition in these groups. This paper constitutes an attempt to propose such normative values. It appears that an extensive review of the literature based, in particular, on the evaluation of UI concentrations recorded in these groups in iodine replete populations does not offer clear answers to the question because of the variability of individual results even in iodine sufficient populations. A first conclusion of this paper is that accurate data should be collected in iodine sufficient countries to compare systematically and at the same time, the UI concentration of the general population, non-pregnant adults, schoolchildren, pregnant and lactating women, and neonates.
However, based on published data, and taking into account the metabolic considerations, it is proposed that the recommended dietary intake of iodine should be 250-300 mg day 21 for pregnant women, 225-350 mg day 21 for lactating women and 90 mg day 21 for neonates and young infants. It is proposed that the median UI concentration that indicates optimal iodine nutrition during pregnancy and lactation should be in the range 150-230 mg l 21 .
Recommendations for neonates are more difficult still, not only because of the lack of accurate data, but also because the neonate is not in a steady state of iodine metabolism and the UI concentration probably represents a relatively imprecise estimation of the iodine intake. However, based on data from the literature and taking into account the theoretical considerations, it can be concluded that the median UI concentration that indicates optimal iodine nutrition in the neonate should be in the range of 180-225 mg l
21
, which is almost the same as the value recommended for mothers.
It has to be emphasised again that these concentrations are higher than those recommended for the general population 19 , and may be linked with side effects in adolescents and non-pregnant adults. For this reason, special attention should be paid to giving iodine supplements, while monitoring the UI concentration during pregnancy and possibly during the neonatal period, in addition to programmes of universal salt iodisation in countries in which there is ID.
Monitoring should include a biochemical evaluation of thyroid function by measuring the serum concentration of TSH, Tg, T 4 , free T 4 and T 3 . Both mothers and infants, but especially infants, are particularly sensitive to ID as their serum TSH is increased and the T 4 concentration decreased, in degrees of ID that do not affect thyroid function in the general population. Systematic neonatal thyroid screening using the concentration of primary TSH is a particularly sensitive index of the degree and impact of ID. After a phase, in which the methods of sampling and doing TSH assays are standardised, it could be the most efficient-if not the single best indicator-used in the process of monitoring the control of ID disorders.
